For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…
Tuberculosis is a highly infectious bacterial infection, and is caused due to Mycobacterium tuberculosis or MTB infection and majorly infects human lungs. Tuberculosis (TB) can be caught by breathing in air that an infected person has contaminated through: Breathing, coughing. Furthermore, the disease is ranked second leading cause of death, after human immunodeficiency virus (HIV). Individual majorly suffer from two predominant forms of TB: Active tuberculosis and Latent tuberculosis. The global tuberculosis testing market comprises diagnostic tests, equipment's and testing procedures that contribute assistance in diagnostic of tuberculosis infection.
LPI (LP Information)' newest research report, the "Tuberculosis Testing Industry Forecast" looks at past sales and reviews total world Tuberculosis Testing sales in 2022, providing a comprehensive analysis by region and market sector of projected Tuberculosis Testing sales for 2023 through 2029. With Tuberculosis Testing sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Tuberculosis Testing industry.
This Insight Report provides a comprehensive analysis of the global Tuberculosis Testing landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Tuberculosis Testing portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms' unique position in an accelerating global Tuberculosis Testing market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Tuberculosis Testing and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Tuberculosis Testing.
The global Tuberculosis Testing market size is projected to grow from US$ 2413.2 million in 2022 to US$ 2824.1 million in 2029; it is expected to grow at a CAGR of 2.3% from 2023 to 2029.
United States market for Tuberculosis Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Tuberculosis Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Tuberculosis Testing is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Tuberculosis Testing players cover Abbott Laboratories, Akonni Biosystems, Abbott, Becton, Dickinson and Company, Cepheid, Epistem Holdings Plc, F. Hoffmann-La Roche AG, Thermo Fischer Scientific and bioMérieux SA, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
This report presents a comprehensive overview, market shares, and growth opportunities of Tuberculosis Testing market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- Smear Microscopy
- Nucleic Acid Testing
- Radiography
- Culture Based Tests
- Drug Susceptibility Testing
- Others
Segmentation by application
- Hospitals
- Laboratories
- Others
This report also splits the market by region:
- Americas
- - United States
- - Canada
- - Mexico
- - Brazil
- APAC
- - China
- - Japan
- - Korea
- - Southeast Asia
- - India
- - Australia
- Europe
- - Germany
- - France
- - UK
- - Italy
- - Russia
- Middle East & Africa
- - Egypt
- - South Africa
- - Israel
- - Turkey
- - GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
- Abbott Laboratories
- Akonni Biosystems
- Abbott
- Becton, Dickinson and Company
- Cepheid
- Epistem Holdings Plc
- F. Hoffmann-La Roche AG
- Thermo Fischer Scientific
- bioMérieux SA
- Siemens Healthineer